Drugs Made In America Acquisition (DMAAU) Other Non-Current Assets (2024)

Drugs Made In America Acquisition (DMAAU) reported Other Non-Current Assets of $545833.0 for Q4 2024.

Drugs Made In America Acquisition (DMAAU) Other Non-Current Assets (2024) Analysis & Trends

Drugs Made In America Acquisition has reported Other Non-Current Assets for 1 years, with the latest figure at $545833.0 in Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Assets changed N/A year-over-year to $545833.0; the trailing twelve-month figure through Dec 2024 stood at $545833.0 (changed N/A YoY), and the FY2024 full-year result was $545833.0, changed N/A from the prior year.
  • Other Non-Current Assets for Q4 2024 stood at $545833.0.
  • The five-year high for Other Non-Current Assets was $545833.0 in Q4 2024, with the low at $545833.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -
2 Berto Acquisition 312.46 Mn 312.46 Mn - -
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - -
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -
6 WEN Acquisition 309.15 Mn 309.15 Mn - 31,169.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 447,113.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - -
9 BTC Development 262.16 Mn 262.16 Mn - -
10 Drugs Made In America Acquisition - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 545,833.00